Thyroid carcinoma producing β-human chorionic gonadotropin shows different clinical behavior

Pathol Int. 2018 Apr;68(4):207-213. doi: 10.1111/pin.12639. Epub 2018 Feb 15.

Abstract

Columnar cell variant of papillary thyroid carcinoma (CCV-PTC) is an unusual neoplasm, the clinical behavior of which mainly depends on the encapsulation or infiltration. Patients with extensive extrathyroidal extension usually have an aggressive biological behavior. This study confirmed that beta-human chorionic gonadotropin (β-hCG) secreting invasive CCV-PTC has good prognosis comparing with a cohort of follicular cell differentiated thyroid carcinoma. On the contrary, positive immunoreaction with β-hCG was proved in three anaplastic thyroid carcinoma patients showing aggressive clinical courses. The clinicopathologic characteristics of CCV-PTC and the paraneoplastic syndromes in follicular cell differentiated thyroid carcinoma were further summarized using literature review.

Keywords: clinicopathological feature; columnar cell variant; papillary thyroid carcinoma; paraneoplastic hyperthyroidism; β-hCG.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Follicular / metabolism
  • Adenocarcinoma, Follicular / mortality
  • Adenocarcinoma, Follicular / pathology*
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis
  • Carcinoma, Papillary / metabolism
  • Carcinoma, Papillary / mortality
  • Carcinoma, Papillary / pathology*
  • Chorionic Gonadotropin, beta Subunit, Human / biosynthesis*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Prognosis
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / mortality
  • Thyroid Neoplasms / pathology*
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Chorionic Gonadotropin, beta Subunit, Human